A yeast two-hybrid, systems based approach for the identification of novel pharmaceutical entities

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.7, 1999-07, pp. : 897-915

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The yeast two-hybrid system and its role in drug discovery

By Lentze Nicolas Auerbach Daniel

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 505-515

Informa Healthcare

Access to resources Recommend Favorite

“Renaissance” of the Yeast Two-Hybrid System - Enhanced for Automation and High-Throughput to Support Proteome-Wide Research

Letters in Drug Design & Discovery, Vol. 7, Iss. 10, 2010-12 ,pp. : 765-789

Bentham Science Publishers

Access to resources Recommend Favorite

Taking a Systems Approach to the Identification of Novel Therapeutic Targets and Biomarkers

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 7, 2010-11 ,pp. : 721-734

Bentham Science Publishers

Access to resources Recommend Favorite

A novel approach to sterile pharmaceutical freeze-drying

By Cherry Christopher Lee Albert Millward Huw Cooper Rose Landon John

Pharmaceutical Development and Technology, Vol. 19, Iss. 1, 2014-02 ,pp. : 73-81

Informa Healthcare

Access to resources Recommend Favorite

Computer-aided Identification of Novel DprE1 Inhibitors as Potential Anti-TB Lead Compounds: A Hybrid Virtual-screening and Molecular Dynamics Approach

Letters in Drug Design & Discovery, Vol. 12, Iss. 4, 2015-05 ,pp. : 302-313

Bentham Science Publishers

Access to resources Recommend Favorite